P53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma
dc.contributor.author | Kilinç, N | |
dc.contributor.author | Yaldiz, M | |
dc.date.accessioned | 2024-04-24T17:40:45Z | |
dc.date.available | 2024-04-24T17:40:45Z | |
dc.date.issued | 2004 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of the study was to evaluate the p53 tumor suppressor gene, c-erbB-2 and steroid hormone receptor expression in breast carcinoma by immunohistochemistry and to correlate them with different histopathologic parameters. Materials and Methods: p53, c-erbB-2, steroid hormone receptors and their correlation with age, tumor size, histological grade, axillary lymph-node status, and menopausal status were investigated in 65 breast carcinoma cases. All markers were measured immunohistochemically on paraffin sections. Association between estrogen receptor (ER), progesterone receptor (PgR), p53 and c-erbB-2 expression and clinicopathologic variables were assessed by the chi-square test for qualitative parameters. Results: c-erbB-2 staining was found in 35.3% of breast carcinomas and was associated with ductal subtype and age under 35 (p 0.022, p = 0.003, respectively); p53 staining was seen in 27.6% of cases and was associated with high histological grade and post-menapausal status (p = 0.038, p = 0.002, respectively). Progesterone receptor expression was associated with positive axillary status (p = 0.003). Conclusion: We concluded that expressions of c-erbB-2, p53, ER, and PgR may be used in the evaluation of breast carcinoma. Therefore the present study suggests that p53 expression is a marker of high histological grade in postmenopausal status, and that c-erbB-2 expression is associated with histologically ductal subtype. | en_US |
dc.identifier.endpage | 610 | en_US |
dc.identifier.issn | 0392-2936 | |
dc.identifier.issn | 2709-0086 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 15493177 | |
dc.identifier.startpage | 606 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/21936 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000224169800016 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Imr Press | en_US |
dc.relation.ispartof | European Journal of Gynaecological Oncology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Breast Carcinoma | en_US |
dc.subject | P53 | en_US |
dc.subject | C-Erbb-2 | en_US |
dc.subject | Estrogen Receptor | en_US |
dc.subject | Progesterone Receptor | en_US |
dc.title | P53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma | en_US |
dc.title | P53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma | |
dc.type | Article | en_US |